Jiangsu Aidea Pharmaceutical Co., Ltd. (688488.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Address
No. 2 Liuzhuang Road
Yangzhou, 225008
China
Phone
86 514 8753 0666
Website
Sector
Healthcare
Industry
Biotechnology
Employees
476
First IPO Date
July 20, 2020
| Name | Title | Pay | Year Born |
| Jie Zhang | Chief Executive Officer, President & Director | 0 | 1971 |
| Gufang Su | Deputy Director of Process R&D | 0 | 1974 |
| Hong Qin | Vice President | 0 | 1981 |
| Jibing Zhang | Factory Manager of Human Protein | 0 | 1967 |
| Qide Li | Director of Pharmaceutical Research Institute | 0 | 1981 |
| Tie Sun | Director of Pharmacology and Toxicology and Senior Director of Biologics R&D | 0 | 1979 |
| Guang Rong Wang | Vice President & Director | 0 | 1978 |
| Yu Yuan | Quality Center Director | 0 | 1980 |
| Gaohong Gu | Senior Vice President | 0 | 1968 |
| Yan Liu | Financial Director, Secretary & Accounting Supervisor | 0 | 1983 |
Jiangsu Aidea Pharmaceutical Co., Ltd. specializes in the research, manufacturing, and commercialization of diverse pharmaceutical products. Its extensive offerings encompass a range of medications including folium sennae granules, powdered bacillus tablets, clindamycin hydrochloride capsules, sodium bicarbonate tablets, nitrendipine tablets, metronidazole tablets, compound gentamycin sulfate and procaine hydrochloride sulfate granules, and cefradine capsules. The company also provides pharmaceutical raw materials. Established in 2009, Jiangsu Aidea Pharmaceutical is headquartered in Yangzhou, China.